Table 3.

Demographic, laboratory, and clinical properties according to the revised Atlanta classification

	Revised Atlanta classification		p
	Mild AP (n=81)	Moderate+severe AP (n=19)
Gender, n (%)
Male	28 (34.6%)	12 (63.2%)	0.022
Female	53 (65.4%)	7 (36.8%)
Etiology, n (%)
Gallstone	48 (59.3%)	13 (68.4%)	0.46
Other causes	33 (40.7%)	6 (31.6%)
Procalcitonin, ng/mL	0.10 (0.17)	0.52 (1.28)	<0.001
Procalcitonin48, ng/mL	0.06 (0.18)	1.07 (5.04)	<0.001
CRP, mg/L	7.8 (14.90)	32 (101.60)	0.001
CRP48, mg/L	28 (74.29)	170 (73)	<0.001
NLR	5.01 (5.10)	16 (13.81)	<0.001
NLR48	2.42 (2)	12 (7.24)	<0.001
Amylase, IU/L	1459 (1516)	1865 (1295)	0.255
Local complication, n (%)	0 (0%)	10 (52.6%)	<0.001
Systemic complication, n (%)	0 (0%)	16 (84.2%)	<0.001
Surgical treatment, n (%)	21 (25.9%)	8 (42.1%)	0.162

NLR: neutrophil-to-lymphocyte ratio; CRP: C-reactive protein

Parameters were expressed as median (IQR) and mean±SD; parameters with 48 written beside them are values measured at 48 h